Experimental Gene Therapy

Share this post

Females have More Adverse Events with BNT162b2!

robertchandler.substack.com

Females have More Adverse Events with BNT162b2!

Very Strong Signal regarding disproportionate Adverse Events and Adverse Events of Special Interest in Females. Revised with numbers verified using Joel Smalley's 2.1 data file. Changes in Notes.

Robert W. Chandler, MD MBA
Aug 13, 2022
4
2
Share this post

Females have More Adverse Events with BNT162b2!

robertchandler.substack.com

Sex Diffs F Substack
490KB ∙ PDF File
Download
Download

Thanks for reading Experimental Gene Therapy! Subscribe for free to receive new posts and support my work.

2
Share this post

Females have More Adverse Events with BNT162b2!

robertchandler.substack.com
2 Comments
author
Robert W. Chandler, MD MBA
Mar 2Author

Thank you for reading them.

Burkhardt 2 is almost ready to go, 106 slides mostly histopath.

Part 3 will be a series of histopath cases from the published literature.

Part 4 will be an analysis and synthesis.

The goal is to determine if we are dealing with a cluster of new diseases.

Expand full comment
Reply
HatariMama
Writes What The Heck In The World
Mar 2

Excellent! Thank you for your work!

Expand full comment
Reply
TopNewCommunity

No posts

Ready for more?

© 2023 Robert W. Chandler, MD MBA
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing